Literature DB >> 7035367

Group B, type III streptococcal cell wall: composition and structural aspects revealed through endo-N-acetylmuramidase-catalyzed hydrolysis.

B J De Cueninck, G D Shockman, R M Swenson.   

Abstract

Cell walls from a group B, type III streptococcus strain were prepared, purified by extraction with sodium dodecyl sulfate, and solubilized by the M-1 fraction of mutanolysin, an endo-N-acetylmuramidase obtained from Streptomyces globisporus. The lysate was resolved into three fractions by ion-exchange chromatography: a fraction containing peptidoglycan (PG) fragments, free of neutral and acidic sugars and of phosphate; a complex of PG fragments and group B-specific polysaccharide; and a complex of PG fragments and group B-specific polysaccharide and type III-specific polysaccharide. The PG-polysaccharide complexes were large and heterogeneous in molecular size. When subjected to base-catalyzed beta-elimination, both complexes were disintegrated, and polysaccharides and low-molecular-weight PG fragments could then be separated by gel filtration. The low-molecular-weight PG fragment-containing fraction contained muramic acid, glucosamine, alanine, lysine, glutamic acid, and serine in molar ratios (to lysine) of 0.92:0.98:3.01:1.00:1.00:0.05. Wall-derived, purified group polysaccharide contained rhamnose, galactose, glucosamine, and phosphorus in molar ratios (to galactose) of 5.03:1.00:1.00:1.05. It also contained an unidentified sugar. Wall-derived, purified type III polysaccharide contained galactose, glucosamine, glucose, and N-acetylneuraminic acid in molar ratios (to glucose) of 1.94:0.85:1.00:1.39. On a dry-weight basis, the whole wall lysate contained 19.8 and 20.6% of group and type polysaccharide, respectively. Neither glycerol nor ribitol was found, and all of the cell wall phosphorus was accounted for as polysaccharide, indicating the absence of a wall teichoic acid.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7035367      PMCID: PMC351079          DOI: 10.1128/iai.35.2.572-581.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

1.  Group B streptococcal neonatal and infant infections.

Authors:  R A Franciosi; J D Knostman; R A Zimmerman
Journal:  J Pediatr       Date:  1973-04       Impact factor: 4.406

2.  Transmission of group B streptococci among parturient women and their neonates.

Authors:  C J Baker; F F Barrett
Journal:  J Pediatr       Date:  1973-12       Impact factor: 4.406

3.  The isolation and some physiochemical and biologic properties of the type 3 antigen of group B streptococci.

Authors:  H Russell; N L Norcross
Journal:  J Immunol       Date:  1972-07       Impact factor: 5.422

Review 4.  The determination of carbohydrate in biological materials by gas-liquid chromatography.

Authors:  J R Clamp; T Bhatti; R E Chambers
Journal:  Methods Biochem Anal       Date:  1971

5.  Use of bacteriolytic enzymes in determination of wall structure and their role in cell metabolism.

Authors:  J M Ghuysen
Journal:  Bacteriol Rev       Date:  1968-12

6.  Cell walls of Streptococcus pyogenes, type 14. C polysaccharide-peptidoglycan and G polysaccharide-peptidoglycan complexes.

Authors:  E Munoz; J M Ghuysen; H Heymann
Journal:  Biochemistry       Date:  1967-12       Impact factor: 3.162

7.  Adjuvant properties of bacterial cell wall mucopeptides.

Authors:  J B Holton; J H Schwab
Journal:  J Immunol       Date:  1966-01       Impact factor: 5.422

8.  Type-specific polysaccharide antigens of group B streptococci.

Authors:  R C Lancefield; E H Freimer
Journal:  J Hyg (Lond)       Date:  1966-06

9.  The peptide N alpha-(L-alanyl-D-isoglutaminyl)-N epsilon-(D-isoasparaginyl)-L-lysyl-D-alanine and the disaccharide N-acetylglucosaminyl-beta-1,4-N-acetylmuramic acid in cell wall peptidoglycan of Streptococcus faecalis strain ATCC 9790.

Authors:  J M Ghuysen; E Bricas; M Leyh-Bouille; M Lache; G D Shockman
Journal:  Biochemistry       Date:  1967-08       Impact factor: 3.162

10.  Type-specific polysaccharide antigens of group B streptococci. II. The chemical basis for serological specificity of the type II HCl antigen.

Authors:  E H Freimer
Journal:  J Exp Med       Date:  1967-03-01       Impact factor: 14.307

View more
  24 in total

1.  Sialylation of group B streptococcal capsular polysaccharide is mediated by cpsK and is required for optimal capsule polymerization and expression.

Authors:  D O Chaffin; L M Mentele; C E Rubens
Journal:  J Bacteriol       Date:  2005-07       Impact factor: 3.490

2.  Deletion of repeats in the alpha C protein enhances the pathogenicity of group B streptococci in immune mice.

Authors:  C Gravekamp; B Rosner; L C Madoff
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

3.  Decreased capacity for type-specific-antigen synthesis accounts for high prevalence of nontypeable strains of group B streptococci in Mexico.

Authors:  G C Palacios; E K Eskew; F Solorzano; S J Mattingly
Journal:  J Clin Microbiol       Date:  1997-11       Impact factor: 5.948

4.  Effective murolytic solubilization of streptococcal-group-specific antigen.

Authors:  C Lämmler; C Frede; H Blobel
Journal:  J Clin Microbiol       Date:  1986-11       Impact factor: 5.948

5.  Synthesis and immunological properties of conjugates composed of group B streptococcus type III capsular polysaccharide covalently bound to tetanus toxoid.

Authors:  T Lagergard; J Shiloach; J B Robbins; R Schneerson
Journal:  Infect Immun       Date:  1990-03       Impact factor: 3.441

6.  Penicillin-binding protein 1a promotes resistance of group B streptococcus to antimicrobial peptides.

Authors:  Andrea Hamilton; David L Popham; David J Carl; Xavier Lauth; Victor Nizet; Amanda L Jones
Journal:  Infect Immun       Date:  2006-11       Impact factor: 3.441

7.  Biosynthesis of cell wall peptidoglycan and polysaccharide antigens by protoplasts of type III group B Streptococcus.

Authors:  M K Yeung; S J Mattingly
Journal:  J Bacteriol       Date:  1983-04       Impact factor: 3.490

8.  Biosynthetic capacity for type-specific antigen synthesis determines the virulence of serotype III strains of group B streptococci.

Authors:  M K Yeung; S J Mattingly
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

9.  Peptidoglycan cross-linking and teichoic acid attachment in Streptococcus pneumoniae.

Authors:  H Fischer; A Tomasz
Journal:  J Bacteriol       Date:  1985-07       Impact factor: 3.490

10.  Teichoic acids of Streptococcus agalactiae: chemistry, cytotoxicity, and effect on bacterial adherence to human cells in tissue culture.

Authors:  J C Goldschmidt; C Panos
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.